Eiger to add Peginterferon Lambda to Covid-19 trial in Brazil,

Clinical outcome comparing emergency room visits and/or hospitalisation in each active arm against placebo will form the primary endpoint of the trial., Clinical outcome comparing emergency room visits and/or hospitalisation in each active arm against placebo will form the primary endpoint of the trial., Read More

Scroll to Top